Market Research Logo

Metabolite Chemistry Reagents - Medical Devices Pipeline Assessment, 2017

Metabolite Chemistry Reagents - Medical Devices Pipeline Assessment, 2017

Summary

GlobalData's Medical Devices sector report, “Metabolite Chemistry Reagents - Medical Devices Pipeline Assessment, 2017 provides an overview of Metabolite Chemistry Reagents currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Metabolite Chemistry Reagents pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Metabolite Chemistry Reagents under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Metabolite Chemistry Reagents and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Metabolite Chemistry Reagents under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date


1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Metabolite Chemistry Reagents Overview
3 Products under Development
3.1 Metabolite Chemistry Reagents - Pipeline Products by Stage of Development
3.2 Metabolite Chemistry Reagents - Pipeline Products by Territory
3.3 Metabolite Chemistry Reagents - Pipeline Products by Regulatory Path
4 Metabolite Chemistry Reagents - Pipeline Products under Development by Companies
4.1 Metabolite Chemistry Reagents Companies - Pipeline Products by Stage of Development
4.2 Metabolite Chemistry Reagents - Pipeline Products by Stage of Development
5 Metabolite Chemistry Reagents Companies and Product Overview
5.1 A/C Diagnostics LLC Company Overview
5.1.1 A/C Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview
5.2 Advanced Liquid Logic Inc Company Overview
5.2.1 Advanced Liquid Logic Inc Pipeline Products & Ongoing Clinical Trials Overview
5.3 Alfa Wassermann Diagnostic Technologies, LLC Company Overview
5.3.1 Alfa Wassermann Diagnostic Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview
5.4 Analyticon Biotechnologies AG Company Overview
5.4.1 Analyticon Biotechnologies AG Pipeline Products & Ongoing Clinical Trials Overview
5.5 BG Medicine Inc Company Overview
5.5.1 BG Medicine Inc Pipeline Products & Ongoing Clinical Trials Overview
5.6 Genesis Detection Systems, Inc. Company Overview
5.6.1 Genesis Detection Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.7 Healthmed Services Ltd. (Inactive) Company Overview
5.7.1 Healthmed Services Ltd. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.8 Instrumentation Laboratory Company Company Overview
5.8.1 Instrumentation Laboratory Company Pipeline Products & Ongoing Clinical Trials Overview
5.9 iXensor Co. Ltd. Company Overview
5.9.1 iXensor Co. Ltd. Pipeline Products & Ongoing Clinical Trials Overview
5.10 Luminor Medical Technologies Inc Company Overview
5.10.1 Luminor Medical Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
5.11 Ohmx Corp Company Overview
5.11.1 Ohmx Corp Pipeline Products & Ongoing Clinical Trials Overview
5.12 Siemens Healthcare GmbH Company Overview
5.12.1 Siemens Healthcare GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.13 The Binding Site Group Ltd Company Overview
5.13.1 The Binding Site Group Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.14 Versantis AG Company Overview
5.14.1 Versantis AG Pipeline Products & Ongoing Clinical Trials Overview
6 Metabolite Chemistry Reagents- Recent Developments
6.1 Aug 01, 2017: llumina Reports Strong Financial Results for Second Quarter of Fiscal Year 2017
6.2 Aug 01, 2017: Illumina Reports Strong Financial Results for Second Quarter of Fiscal Year 2017
6.3 Jul 28, 2017: Merck Announces Second-Quarter 2017 Financial Results
6.4 Jul 20, 2017: Abbott Reports Second-Quarter 2017 Results
6.5 Jul 17, 2017: Governor Abbott Announces Merck IT Hub In Austin
6.6 Jul 03, 2017: Premaitha Health Litigation Update
6.7 Jun 21, 2017: Immunodiagnostic Systems Holdings: Final Results for year ended 31 March 2017
6.8 May 22, 2017: Illumina Names Mark Van Oene Chief Commercial Officer, Sales Leader Brings Genomics Expertise and Strong Commercial Leadership Experience to the Role
6.9 May 18, 2017: Aalto Bio Reagents Launches West Nile Virus Native and Recombinant Proteins for Diagnostic Testing
6.10 May 02, 2017: Merck Announces First-Quarter 2017 Financial Results
6.11 May 02, 2017: Oxford Immunotec Reports First Quarter 2017 Financial Results
6.12 Apr 25, 2017: Illumina Reports Financial Results for First Quarter of Fiscal Year 2017
6.13 Apr 19, 2017: Abbott Reports First-Quarter 2017 Results
6.14 Apr 10, 2017: Dr. John H. Noseworthy Nominated to Stand for Election to Merck Board of Directors
6.15 Apr 06, 2017: Merck Receives 2017 ENERGY STAR Sustained Excellence Award from U. S. Environmental Protection Agency
6.16 Mar 31, 2017: HORIBA Instruments commences operations at new factory in Houston
6.17 Mar 31, 2017: City Of Austin Announces Merck Economic Development Proposal
6.18 Mar 20, 2017: EKF Diagnostics Holdings: Final results
6.19 Mar 13, 2017: Immunodiagnostic Systems Holdings Re-Appoints CEO
6.20 Feb 24, 2017: Immunodiagnostic Systems Holdings: Update on CEO Appointment
6.21 Feb 20, 2017: Illumina Names John W. Thompson to Its Board of Directors, Bringing More Than 40 Years of Technology Leadership to Illumina
6.22 Feb 02, 2017: Merck Announces Fourth-Quarter and Full-Year 2016 Financial Results
6.23 Jan 31, 2017: Illumina Reports Full Financial Results for Fourth Quarter and Fiscal Year 2016
6.24 Jan 27, 2017: Illumina Names Caroline Dorsa to Its Board of Directors, Adding Over 30 Years of Leadership Experience in the Healthcare, Telecommunications and Energy Industries
6.25 Jan 27, 2017: Omega Diagnostics Group: Update on discussions with Immunodiagnostic Systems Holdings
6.26 Jan 25, 2017: Daktari Achieves Milestone in Its Merck HCV Collaboration
6.27 Jan 19, 2017: Immunodiagnostic Systems Holdings Announces Directorate Change
6.28 Jan 03, 2017: Illumina Taps Garret Hampton, One of the World’s Leading Clinical Genomics Experts, to Head its Clinical Genomics Unit
6.29 Dec 22, 2016: Bionaturis Group gets a new patent in USA innovating in the use of natural resources to produce pharmaceutical products
6.30 Dec 20, 2016: Illumina Names Jonathan Seaton as Senior Vice President for Corporate & Business Development, Adding Further Clinical and Life Sciences Expertise to its Executive Team
6.31 Dec 14, 2016: Beckman Coulter appoints IT Product Manager for Northern Europe
6.32 Dec 14, 2016: Siemens Healthineers to significantly expand its Walpole, Mass. Laboratory Diagnostic manufacturing facility
6.33 Dec 07, 2016: Illumina appoints senior vice president and CFO
6.34 Dec 07, 2016: Illumina Extends Management Team, Appoints Sam A. Samad as Senior Vice President and Chief Financial Officer
6.35 Nov 25, 2016: Immunodiagnostic Systems Holdings: Interim Results for the six month period ended 30 September 2016
6.36 Nov 01, 2016: Oxford Immunotec Reports Third Quarter 2016 Financial Results
6.37 Nov 01, 2016: Illumina Reports Full Financial Results for Third Quarter of Fiscal Year 2016
6.38 Oct 25, 2016: Merck Announces Third-Quarter 2016 Financial Results
6.39 Oct 21, 2016: Immunodiagnostic Systems Holdings: H1 Trading Update
6.40 Oct 19, 2016: Abbott Reports Third-Quarter 2016 Results
6.41 Oct 10, 2016: Illumina Announces Preliminary Revenue for Third Quarter of Fiscal Year 2016
6.42 Sep 12, 2016: EKF Diagnostics Holdings: Half-year Report
7 Appendix
7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer
1.1 List of Tables
Table 1: Metabolite Chemistry Reagents - Pipeline Products by Stage of Development
Table 2: Metabolite Chemistry Reagents - Pipeline Products by Territory
Table 3: Metabolite Chemistry Reagents - Pipeline Products by Regulatory Path
Table 4: Metabolite Chemistry Reagents Companies - Pipeline Products by Stage of Development
Table 5: Metabolite Chemistry Reagents - Pipeline Products by Stage of Development
Table 6: A/C Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 7: Folate Enzymatic Assay - Product Status
Table 8: Folate Enzymatic Assay - Product Description
Table 9: Advanced Liquid Logic Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 10: Total Serum Biliruibin Multiplex Assay - Product Status
Table 11: Total Serum Biliruibin Multiplex Assay - Product Description
Table 12: Alfa Wassermann Diagnostic Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 13: ACE Alera Clinical Chemistry System - Neonatal Bilirubin Assay - Product Status
Table 14: ACE Alera Clinical Chemistry System - Neonatal Bilirubin Assay - Product Description
Table 15: Analyticon Biotechnologies AG Pipeline Products & Ongoing Clinical Trials Overview
Table 16: BIL-Direct JG Fluitest - Product Status
Table 17: BIL-Direct JG Fluitest - Product Description
Table 18: BIL-Total JG Fluitest - Product Status
Table 19: BIL-Total JG Fluitest - Product Description
Table 20: BIL-Total VBM Fluitest - Product Status
Table 21: BIL-Total VBM Fluitest - Product Description
Table 22: BIL-Total WG Fluitest - Product Status
Table 23: BIL-Total WG Fluitest - Product Description
Table 24: BILD-DCA Fluitest - Product Status
Table 25: BILD-DCA Fluitest - Product Description
Table 26: BILT-DCA Fluitest - Product Status
Table 27: BILT-DCA Fluitest - Product Description
Table 28: CHOL - HDL Direct Fluitest - Product Status
Table 29: CHOL - HDL Direct Fluitest - Product Description
Table 30: CHOL - LDL Direct Fluitest - Product Status
Table 31: CHOL - LDL Direct Fluitest - Product Description
Table 32: CHOL - LDL Fluitest - Product Status
Table 33: CHOL - LDL Fluitest - Product Description
Table 34: CHOL CHOD-PAP Lyophilisat - Product Status
Table 35: CHOL CHOD-PAP Lyophilisat - Product Description
Table 36: CHOL Fluitest - Product Status
Table 37: CHOL Fluitest - Product Description
Table 38: Fluitest ALB-BCG - Product Status
Table 39: Fluitest ALB-BCG - Product Description
Table 40: Fluitest BIL - Direct Walters/Gerarde - Product Status
Table 41: Fluitest BIL - Direct Walters/Gerarde - Product Description
Table 42: Fluitest BIL T/D - Product Status
Table 43: Fluitest BIL T/D - Product Description
Table 44: Fluitest CHOL-HDL Phosphotungstic Acid/Magnesium Chloride - Product Status
Table 45: Fluitest CHOL-HDL Phosphotungstic Acid/Magnesium Chloride - Product Description
Table 46: Fluitest CREA - Kinetic - Product Status
Table 47: Fluitest CREA - Kinetic - Product Description
Table 48: Fluitest FE FZ - Product Status
Table 49: Fluitest FE FZ - Product Description
Table 50: Fluitest FRUC - Product Status
Table 51: Fluitest FRUC - Product Description
Table 52: Fluitest GLU GOD-PAP - Product Status
Table 53: Fluitest GLU GOD-PAP - Product Description
Table 54: Fluitest LA PAP - Product Status
Table 55: Fluitest LA PAP - Product Description
Table 56: GLU GOD - PAP Lyophilisat - Product Status
Table 57: GLU GOD - PAP Lyophilisat - Product Description
Table 58: HbA1 Ion Exchange Batch Assay - Product Status
Table 59: HbA1 Ion Exchange Batch Assay - Product Description
Table 60: HbA1c Micro Column Assay - Product Status
Table 61: HbA1c Micro Column Assay - Product Description
Table 62: Turbitex FER - Product Status
Table 63: Turbitex FER - Product Description
Table 64: Turbitex HbA1c/Hb Assay - Product Status
Table 65: Turbitex HbA1c/Hb Assay - Product Description
Table 66: BG Medicine Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 67: LipidDx - Product Status
Table 68: LipidDx - Product Description
Table 69: Genesis Detection Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 70: Rapid Home Test - HDL/LDL Cholesterol - Product Status
Table 71: Rapid Home Test - HDL/LDL Cholesterol - Product Description
Table 72: Healthmed Services Ltd. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 73: Glycated Albumin Test - Product Status
Table 74: Glycated Albumin Test - Product Description
Table 75: Instrumentation Laboratory Company Pipeline Products & Ongoing Clinical Trials Overview
Table 76: GEM Premier 4000 Analyzer - BUN - Product Status
Table 77: GEM Premier 4000 Analyzer - BUN - Product Description
Table 78: iXensor Co. Ltd. Pipeline Products & Ongoing Clinical Trials Overview
Table 79: Uric Acid Test - Product Status
Table 80: Uric Acid Test - Product Description
Table 81: Luminor Medical Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 82: Next Generation PreVu LP Test - Product Status
Table 83: Next Generation PreVu LP Test - Product Description
Table 84: Ohmx Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 85: Diagnostic Test - FAD Metabolite - Product Status
Table 86: Diagnostic Test - FAD Metabolite - Product Description
Table 87: Siemens Healthcare GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 88: ADVIA 1800 Chemistry System - Creatinine Validity Test - Product Status
Table 89: ADVIA 1800 Chemistry System - Creatinine Validity Test - Product Description
Table 90: The Binding Site Group Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 91: Albumin Urine SPAplus Kit - Product Status
Table 92: Albumin Urine SPAplus Kit - Product Description
Table 93: Versantis AG Pipeline Products & Ongoing Clinical Trials Overview
Table 94: TS-01 - Product Status
Table 95: TS-01 - Product Description
Table 96: Glossary
1.2 List of Figures
Figure 1: Metabolite Chemistry Reagents - Pipeline Products by Stage of Development
Figure 2: Metabolite Chemistry Reagents - Pipeline Products by Territory
Figure 3: Metabolite Chemistry Reagents - Pipeline Products by Regulatory Path

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report